Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOB | P27338 | 2/20 | 0.52 |
| ▸ | IMPDH2 | P12268 | 1/20 | 0.44 |
| ▸ | AS3MT | Q9HBK9 | 1/20 | 0.44 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.40 |
| ▸ | FNTA | P49354 | 1/20 | 0.40 |
| ▸ | FNTB | P49356 | 1/20 | 0.40 |
| ▸ | PGGT1B | P53609 | 1/20 | 0.40 |
| ▸ | LMNA | P02545 | 1/20 | 0.40 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.40 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.40 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.40 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.40 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.40 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.40 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.40 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.40 |
| ▸ | MAP2K1 | Q02750 | 1/20 | 0.39 |
| ▸ | RET | P07949 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31458801 | 0.88 | RET (0.46) | MAOBCYP19A1RET | |
| SCHEMBL29566683 | 0.81 | RET (0.45) | RET | |
| SCHEMBL25252185 | 0.81 | CDK2 (0.36) | MAP2K1RET | |
| SCHEMBL30175370 | 0.81 | CDK2 (0.36) | MAP2K1RET | |
| SCHEMBL31416740 | 0.80 | RAB9A (0.43) | MAOBLMNACYP1A2PTGS1SLC6A2 | |
| Hydrochloric Acid SCHEMBL28993707 | 0.80 | RET (0.44) | RET | |
| SCHEMBL30175312 | 0.78 | MAOA (0.35) | MAOBPTGS2MAP2K1RET | |
| SCHEMBL30175296 | 0.78 | RET (0.45) | RET | |
| SCHEMBL30175335 | 0.78 | RET (0.37) | MAP2K1RET | |
| SCHEMBL30175349 | 0.78 | CYP11B1 (0.41) | RET |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-112574235-B | RET inhibitor, pharmaceutical composition and application thereof | 广东东阳光药业股份有限公司 | 2024-01-16 | — | — | CN | disclosed |